[The effect of recombinant human erythropoietin on postoperative anemia in orthognathic patients].

Purpose: To observe the effect of rhEPO on postoperative anemia in orthognathic patients.

Methods: 31 patients had 500-1200 ml blood loss during orthognathic operation, who were divided into two groups randomly, the experiment group and the control group. The patients in the experiment group received rhEPO 6000IU subcutaneously for 3 times in a week and Ferrost sulfatis Et vitamini-medtech 1 tablet per day via oral administration for 12 days after operation, while the patients in the control group only received the same dose of Ferrost sulfatis Et vitamini-medtech.